References
- Walker SH. Effect of the covid pandemic on progestogen-only and oestrogen-containing contraceptive prescribing in general practice: a retrospective analysis of english prescribing data. Eur J Contracept Reprod Health Care. 2022;27(4):272–277.
- Coombe J, Kong F, Bittleston H, et al. Contraceptive use and pregnancy plans among women of reproductive age during the first Australian COVID-19 lockdown: findings from an online survey. Eur J Contracept Reprod Health Care. 2021;26(4):265–271.
- Charles CM, Munezero A, Bahamondes LG, et al. Comparison of contraceptive sales before and during the COVID-19 pandemic in Brazil. Eur J Contracept Reprod Health Care. 2022;27(2):115–120.
- Murtada R, Carbonnel M, Revaux A, et al. Managing an obstetrics and gynaecology department in time of COVID pandemic: safety and efficacy first at foch hospital. Eur J Contracept Reprod Health Care. 2020;25(4):321–322.
- Dixon A, Reynolds-Wright JJ, Cameron ST. Uptake of long-acting reversible contraception after telemedicine delivered abortion during covid-19. Eur J Contracept Reprod Health Care. 2022;27(4):284–288.
- Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;1:m3320.
- Steenland MW, Geiger CK, Chen L, et al. Declines in contraceptive visits in the United States during the COVID-19 pandemic. Contraception. 2021;104(6):593–599.
- Balachandren N, Barrett G, Stephenson JM, et al. Impact of the SARS-CoV-2 pandemic on access to contraception and pregnancy intentions: a national prospective cohort study of the UK population. BMJ Sex Reprod Health. 2022;48(1):60–65.
- Sonalkar S, Kapp N. Intrauterine device insertion in the postpartum period: a systematic review. Eur J Contracept Reprod Health Care. 2015;20(1):4–18.
- Immediate Postpartum Long-Acting Reversible Contraception. Committee Opinion, number 670. 2016. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2016/08/immediate-postpartum-long-acting-reversible-contraception
- Fruzzetti F, Cagnacci A, Primiero F, et al. Contraception during Coronavirus-Covid 19 pandemia. Recommendations of the board of the Italian society of contraception. Eur J Contracept Reprod Health Care. 2020;25(3):231–232.
- Ministério da Saúde. Boletins epidemiológicos COVID-19. https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/covid-19/2020
- Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. Medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep. 2016;65(3):1–103.
- World Health Organization. Contraception/Family planning and COVID-19. https://www.who.int/news-room/q-a-detail/contraception-family-planning-and-covid-19
- Kraft MBPL, Miadaira M, Marangoni M, Jr, et al. Postplacental placement of intrauterine devices: acceptability, reasons for refusal and proposals to increase its use. Rev Bras Ginecol Obstet. 2021;43(3):172–177.
- Divakar H, Bhardwaj A, Purandare CN, et al. Critical Factors influencing the acceptability of post-placental insertion of intrauterine contraceptive device: a study in six public/private institutes in India. J Obstet Gynaecol India. 2019;69(4):344–349.
- Yates M, Styles D, Janes J, et al. Identifying barriers to post-placental intrauterine device placement: male partners’ views. Eur J Contracept Reprod Health Care. 2020;25(2):159–165.
- Friedman JO. Factors associated with contraceptive satisfaction in adolescent women using the IUD. J Pediatr Adolesc Gynecol. 2015;28(1):38–42.
- Sanders JN, Turok DK, Gawron LM, et al. Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review. Am J Obstet Gynecol. 2017;216(6):590.e1–590.e8.
- Bateson D, Harvey C, Trinh L, et al. User characteristics, experiences and continuation rates of copper intrauterine device use in a cohort of Australian women. Aust N Z J Obstet Gynaecol. 2016;56(6):655–661.
- Dewan R, Bharti N, Mittal A, et al. Early IUD insertion after medically induced abortion. Eur J Contracept Reprod Health Care. 2018;23(3):231–236.
- Sheyn D, Arora KS. Changes in rates of inpatient postpartum Long-Acting reversible contraception and sterilization in the USA, 2012-2016. Matern Child Health J. 2021;25(10):1562–1573.
- Garcia EAL, Ferreira JM, Veiga-Junior N, et al. Knowledge, attitude, and practices related to the SARS-CoV-2 pandemic among women seeking contraceptive methods. Rev Bras Ginecol Obstet. 2022;44(4):391–397.
- Averbach SH, Ermias Y, Jeng G, et al. Expulsion of intrauterine devices after postpartum placement by timing of placement, delivery type, and intrauterine device type: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;223(2):177–188.
- Ferreira PB, Utiyama RY, Tamanaha S, et al. Immediate Postpartum copper IUD: a comparative analysis between profiles of women who accept and who refuse it. Rev Bras Ginecol Obstet. 2022;44(2):154–160.
- Washington CI, Jamshidi R, Thung SF, et al. Timing of postpartum intrauterine device placement: a cost-effectiveness analysis. Fertil Steril. 2015;103(1):131–137.
- Laporte M, Marangoni M, Jr, Surita F, et al. Postplacental placement of intrauterine devices: a randomized clinical trial. Contraception. 2020;101(3):153–158.